ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE

ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE was reported 4794 times

ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TOTAL LUNG CAPACITY INCREASED 6 0.0221
1 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 6 0.0115
2 AUTISM SPECTRUM DISORDER 50 0.0091
3 ACUTE HEPATIC FAILURE 88 0.0064
4 HOARSENESS 3 0.0062
5 PULMONARY ARTERY STENOSIS CONGENITAL 4 0.0055
6 SUSPECTED SUICIDE 22 0.0047
7 CERVICAL RADICULOPATHY 3 0.0042
8 ATROPHIC VULVOVAGINITIS 3 0.0041
9 CARTILAGE ATROPHY 3 0.0037
10 FEAR OF FALLING 3 0.0037
11 LUMBAR RADICULOPATHY 4 0.0035
12 PULMONARY VALVE INCOMPETENCE 5 0.0034
13 HEPATORENAL SYNDROME 5 0.0030
14 DRUG ADMINISTRATION ERROR 90 0.0029
15 HEPATIC NECROSIS 11 0.0029
16 PROTHROMBIN TIME PROLONGED 17 0.0028
17 HAEMORRHAGIC ANAEMIA 12 0.0027
18 SELF INJURIOUS BEHAVIOUR 8 0.0026
19 DILATATION ATRIAL 3 0.0026
20 PRE-EXISTING CONDITION IMPROVED 16 0.0026
21 COSTOCHONDRITIS 4 0.0025
22 PRODUCT ADMINISTRATION ERROR 49 0.0024
23 BLOOD PRESSURE DIASTOLIC ABNORMAL 6 0.0024
24 RHINITIS ALLERGIC 10 0.0022
25 ESSENTIAL HYPERTENSION 4 0.0022
26 CHRONIC FATIGUE SYNDROME 3 0.0022
27 COMPLETED SUICIDE 171 0.0020
28 TACHYPHRENIA 7 0.0020
29 GASTROINTESTINAL WALL THICKENING 3 0.0020
30 MUSCLE CONTRACTURE 4 0.0020
31 INTENTIONAL OVERDOSE 123 0.0019
32 ANTICHOLINERGIC SYNDROME 3 0.0019
33 AORTIC VALVE INCOMPETENCE 8 0.0019
34 C-REACTIVE PROTEIN ABNORMAL 12 0.0019
35 SOMNAMBULISM 12 0.0018
36 COLONOSCOPY 4 0.0018
37 RED BLOOD CELL COUNT INCREASED 5 0.0018
38 SKIN HYPERTROPHY 5 0.0018
39 BLOOD PRESSURE DIASTOLIC INCREASED 8 0.0017
40 JAUNDICE CHOLESTATIC 6 0.0017
41 DRUG MONITORING PROCEDURE NOT PERFORMED 3 0.0017
42 HYPOMANIA 6 0.0016
43 CHEST X-RAY ABNORMAL 5 0.0016
44 ULCER HAEMORRHAGE 11 0.0016
45 LOWER GASTROINTESTINAL HAEMORRHAGE 12 0.0016
46 BLOOD PRESSURE SYSTOLIC ABNORMAL 4 0.0016
47 MULTIPLE DRUG OVERDOSE 8 0.0016
48 BLADDER SPASM 3 0.0016
49 MATERNAL EXPOSURE TIMING UNSPECIFIED 6 0.0016
50 VENTRICULAR HYPERTROPHY 4 0.0016
51 SNORING 6 0.0016
52 EXPOSURE VIA INGESTION 4 0.0016
53 ATELECTASIS 15 0.0016
54 DRUG TITRATION ERROR 4 0.0015
55 PRODUCT ADMINISTRATION INTERRUPTED 12 0.0015
56 HEPATIC ENCEPHALOPATHY 14 0.0015
57 ALCOHOL ABUSE 4 0.0015
58 CHOLECYSTITIS CHRONIC 10 0.0015
59 PLANTAR FASCIITIS 5 0.0015
60 SARCOIDOSIS 7 0.0015
61 CARBOHYDRATE ANTIGEN 125 INCREASED 5 0.0015
62 COAGULOPATHY 24 0.0014
63 SELF-INJURIOUS IDEATION 6 0.0014
64 DILATATION VENTRICULAR 3 0.0014
65 ATTENTION DEFICIT HYPERACTIVITY DISORDER 6 0.0014
66 HANGOVER 5 0.0014
67 NASAL POLYPS 7 0.0014
68 EYE CONTUSION 3 0.0014
69 OXYGEN SATURATION ABNORMAL 4 0.0014
70 SUICIDE ATTEMPT 85 0.0014
71 LUNG CANCER METASTATIC 4 0.0014
72 VITAMIN B12 DECREASED 4 0.0014
73 DYSPHEMIA 6 0.0014
74 BRAIN OEDEMA 17 0.0013
75 BRAIN HERNIATION 4 0.0013
76 HAEMATOCRIT INCREASED 3 0.0013
77 BRAIN OPERATION 3 0.0013
78 EAR DISORDER 6 0.0013
79 DYSCHEZIA 4 0.0013
80 COMPRESSION FRACTURE 7 0.0013
81 RECTAL CANCER 4 0.0013
82 TALIPES 4 0.0013
83 FOREIGN BODY IN THROAT 4 0.0013
84 NON-CARDIAC CHEST PAIN 4 0.0013
85 LOOSE TOOTH 4 0.0012
86 BREATH ODOUR 3 0.0012
87 LYMPHOCYTE COUNT INCREASED 4 0.0012
88 CARPAL TUNNEL SYNDROME 17 0.0012
89 HEART INJURY 3 0.0012
90 PEPTIC ULCER 4 0.0012
91 INFREQUENT BOWEL MOVEMENTS 3 0.0012
92 HYPOVOLAEMIA 7 0.0012
93 EYELID IRRITATION 3 0.0012
94 RED BLOOD CELL SEDIMENTATION RATE INCREASED 13 0.0012
95 BLOOD CHLORIDE DECREASED 3 0.0012
96 BLOOD CREATININE ABNORMAL 4 0.0012
97 CARDIAC MURMUR 10 0.0012
98 HERNIA REPAIR 3 0.0012
99 DIVERTICULUM INTESTINAL 5 0.0011
100 SEASONAL ALLERGY 16 0.0011
101 BLOOD POTASSIUM ABNORMAL 3 0.0011
102 TRANSAMINASES INCREASED 25 0.0011
103 ALCOHOL POISONING 3 0.0011
104 LIGAMENT SPRAIN 11 0.0011
105 TOXICITY TO VARIOUS AGENTS 187 0.0011
106 LIVER INJURY 27 0.0011
107 BLOOD PRESSURE SYSTOLIC DECREASED 5 0.0011
108 BLOOD IRON DECREASED 13 0.0011
109 BLOOD PHOSPHORUS DECREASED 4 0.0011
110 HAEMOGLOBIN ABNORMAL 7 0.0011
111 INCREASED TENDENCY TO BRUISE 10 0.0011
112 ALCOHOL USE 4 0.0011
113 FREEZING PHENOMENON 4 0.0011
114 HEPATIC FAILURE 32 0.0011
115 SKIN ATROPHY 6 0.0010
116 GINGIVAL DISORDER 4 0.0010
117 RENAL FAILURE CHRONIC 8 0.0010
118 OESOPHAGEAL ULCER 4 0.0010
119 EYELID MARGIN CRUSTING 3 0.0010
120 HYPERCHOLESTEROLAEMIA 10 0.0010
121 CONCUSSION 8 0.0010
122 SENSATION OF HEAVINESS 4 0.0010
123 VITAMIN D DEFICIENCY 10 0.0010
124 ROTATOR CUFF SYNDROME 13 0.0010
125 DRUG SCREEN POSITIVE 8 0.0010
126 HYPERVOLAEMIA 5 0.0010
127 SKIN LACERATION 11 0.0010
128 TRICUSPID VALVE INCOMPETENCE 8 0.0010
129 SENSORY LOSS 8 0.0010
130 HOMICIDAL IDEATION 4 0.0010
131 ABNORMAL DREAMS 27 0.0010
132 SELF-MEDICATION 4 0.0010
133 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 6 0.0010
134 RED CELL DISTRIBUTION WIDTH INCREASED 4 0.0010
135 ATRIAL SEPTAL DEFECT 8 0.0010
136 HALLUCINATIONS, MIXED 4 0.0010
137 INFUSION SITE PRURITUS 3 0.0009
138 CANDIDA INFECTION 16 0.0009
139 BUNDLE BRANCH BLOCK LEFT 4 0.0009
140 FEELING DRUNK 7 0.0009
141 ESCHERICHIA URINARY TRACT INFECTION 4 0.0009
142 LEFT VENTRICULAR HYPERTROPHY 4 0.0009
143 CARDIAC FLUTTER 6 0.0009
144 BLOOD MAGNESIUM DECREASED 8 0.0009
145 INSOMNIA 245 0.0009
146 ACIDOSIS 7 0.0009
147 JAW DISORDER 5 0.0009
148 ONYCHOMYCOSIS 4 0.0009
149 ASTHENOPIA 5 0.0009
150 LIGAMENT RUPTURE 4 0.0009
151 MUSCULOSKELETAL CHEST PAIN 14 0.0009
152 UPPER LIMB FRACTURE 18 0.0009
153 MENTAL STATUS CHANGES 25 0.0009
154 BRAIN INJURY 9 0.0009
155 MULTIPLE ALLERGIES 7 0.0009
156 BRONCHIECTASIS 6 0.0009
157 CLOSTRIDIAL INFECTION 3 0.0009
158 CHOLELITHIASIS 29 0.0009
159 ACUTE RESPIRATORY FAILURE 17 0.0009
160 PERONEAL NERVE PALSY 5 0.0009
161 INITIAL INSOMNIA 9 0.0009
162 HAEMOGLOBIN INCREASED 4 0.0009
163 CERVICAL VERTEBRAL FRACTURE 3 0.0009
164 AORTIC STENOSIS 3 0.0009
165 CARDIO-RESPIRATORY ARREST 36 0.0009
166 MYDRIASIS 11 0.0009
167 OSTEOPENIA 13 0.0009
168 HEPATOTOXICITY 19 0.0009
169 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
170 SKIN ABRASION 4 0.0008
171 FULL BLOOD COUNT DECREASED 17 0.0008
172 HAEMORRHAGIC DIATHESIS 3 0.0008
173 PRE-ECLAMPSIA 4 0.0008
174 HYPERSOMNIA 24 0.0008
175 DECREASED ACTIVITY 9 0.0008
176 VULVOVAGINAL PAIN 4 0.0008
177 NOCTURIA 10 0.0008
178 INTERVERTEBRAL DISC PROTRUSION 18 0.0008
179 MUSCLE SPASTICITY 10 0.0008
180 HOSPICE CARE 8 0.0008
181 NAIL DISORDER 7 0.0008
182 INTENTIONAL PRODUCT MISUSE 70 0.0008
183 BACK DISORDER 13 0.0008
184 MITRAL VALVE INCOMPETENCE 9 0.0008
185 FACE INJURY 3 0.0008
186 COMMUNICATION DISORDER 3 0.0008
187 GALLBLADDER DISORDER 14 0.0008
188 EAR DISCOMFORT 8 0.0008
189 RIB FRACTURE 16 0.0008
190 BLOOD BILIRUBIN INCREASED 21 0.0008
191 EAR PAIN 15 0.0008
192 FAECES HARD 3 0.0008
193 FAILURE TO THRIVE 4 0.0008
194 VENTRICULAR EXTRASYSTOLES 8 0.0008
195 RESTLESS LEGS SYNDROME 14 0.0008
196 BONE DISORDER 14 0.0008
197 EPIGASTRIC DISCOMFORT 3 0.0008
198 TENDON DISORDER 5 0.0008
199 EXOSTOSIS 7 0.0008
200 POLYP 5 0.0008
201 FURUNCLE 6 0.0008
202 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
203 GASTROINTESTINAL MOTILITY DISORDER 4 0.0007
204 GASTROOESOPHAGEAL REFLUX DISEASE 60 0.0007
205 NIGHT SWEATS 24 0.0007
206 LACERATION 7 0.0007
207 DYSPNOEA EXERTIONAL 28 0.0007
208 BRUXISM 4 0.0007
209 GALLBLADDER OPERATION 3 0.0007
210 SINUS CONGESTION 10 0.0007
211 SPINAL DISORDER 7 0.0007
212 FOOT FRACTURE 14 0.0007
213 SUBSTANCE ABUSE 6 0.0007
214 PRODUCT LABEL ISSUE 5 0.0007
215 SLEEP DISORDER 52 0.0007
216 THERAPEUTIC RESPONSE UNEXPECTED 33 0.0007
217 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
218 HICCUPS 6 0.0007
219 NEPHROTIC SYNDROME 5 0.0007
220 ECCHYMOSIS 5 0.0007
221 ONYCHOCLASIS 5 0.0007
222 CHOKING SENSATION 4 0.0007
223 JOINT EFFUSION 5 0.0007
224 GASTROENTERITIS VIRAL 13 0.0007
225 NEPHROLITHIASIS 33 0.0007
226 DYSSTASIA 21 0.0007
227 HIP ARTHROPLASTY 11 0.0007
228 HAEMORRHOIDS 14 0.0007
229 RENAL TUBULAR NECROSIS 7 0.0007
230 RIGHT VENTRICULAR FAILURE 5 0.0007
231 BLOOD CALCIUM DECREASED 8 0.0007
232 ANKLE FRACTURE 11 0.0007
233 HALLUCINATION, VISUAL 15 0.0007
234 RENAL FAILURE ACUTE 30 0.0007
235 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
236 WHITE BLOOD CELL COUNT INCREASED 27 0.0007
237 DIVERTICULUM 5 0.0007
238 FOETAL EXPOSURE DURING PREGNANCY 57 0.0007
239 SPINAL FRACTURE 14 0.0007
240 THINKING ABNORMAL 13 0.0007
241 CONSTIPATION 152 0.0007
242 NIGHTMARE 24 0.0007
243 PANIC REACTION 5 0.0007
244 EXPIRED PRODUCT ADMINISTERED 23 0.0007
245 HEPATIC CIRRHOSIS 13 0.0007
246 HYPOTHERMIA 7 0.0007
247 TOOTH ABSCESS 7 0.0007
248 NEUTROPHIL COUNT INCREASED 7 0.0007
249 SPINAL OSTEOARTHRITIS 6 0.0007
250 SLEEP APNOEA SYNDROME 13 0.0007
251 LETHARGY 39 0.0007
252 DRY MOUTH 55 0.0007
253 CARDIOMYOPATHY 10 0.0007
254 ATAXIA 8 0.0007
255 SINUS HEADACHE 4 0.0007
256 VERTIGO 41 0.0007
257 POLLAKIURIA 28 0.0007
258 ODYNOPHAGIA 4 0.0007
259 MACULAR DEGENERATION 8 0.0007
260 BLOOD POTASSIUM DECREASED 20 0.0007
261 HEAD INJURY 21 0.0007
262 LEUKOCYTOSIS 12 0.0007
263 TOOTHACHE 12 0.0007
264 ARTHRITIS 52 0.0007
265 HEPATIC ENZYME INCREASED 45 0.0007
266 EATING DISORDER 14 0.0007
267 SINUS DISORDER 13 0.0007
268 UPPER GASTROINTESTINAL HAEMORRHAGE 11 0.0007
269 PROSTATIC SPECIFIC ANTIGEN INCREASED 9 0.0007
270 LIPASE INCREASED 5 0.0007
271 RECTAL HAEMORRHAGE 28 0.0007
272 BLOOD CHOLESTEROL ABNORMAL 3 0.0006
273 PIGMENTATION DISORDER 4 0.0006
274 ORAL DISCOMFORT 9 0.0006
275 ARTHRITIS INFECTIVE 3 0.0006
276 HUNGER 9 0.0006
277 CONGENITAL ANOMALY 5 0.0006
278 AMNESIA 42 0.0006
279 HEPATIC STEATOSIS 12 0.0006
280 DELUSION 10 0.0006
281 FLANK PAIN 6 0.0006
282 MUSCULOSKELETAL DISCOMFORT 11 0.0006
283 ELECTROCARDIOGRAM ABNORMAL 5 0.0006
284 OSTEOARTHRITIS 27 0.0006
285 MUSCLE ATROPHY 8 0.0006
286 PRODUCT PACKAGING ISSUE 6 0.0006
287 PANIC ATTACK 23 0.0006
288 NASAL CONGESTION 37 0.0006
289 RESPIRATORY TRACT CONGESTION 10 0.0006
290 GINGIVAL PAIN 5 0.0006
291 SCREAMING 4 0.0006
292 LIMB INJURY 17 0.0006
293 ORAL PAIN 14 0.0006
294 HYPOXIA 22 0.0006
295 CHRONIC KIDNEY DISEASE 47 0.0006
296 INCOHERENT 4 0.0006
297 NEURALGIA 15 0.0006
298 HEPATITIS ACUTE 4 0.0006
299 POST PROCEDURAL INFECTION 5 0.0006
300 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
301 DECUBITUS ULCER 5 0.0006
302 INCORRECT DOSAGE ADMINISTERED 3 0.0006
303 VITREOUS FLOATERS 6 0.0006
304 HOT FLUSH 46 0.0006
305 GASTROINTESTINAL HAEMORRHAGE 51 0.0006
306 DYSPEPSIA 60 0.0006
307 BREATH SOUNDS ABNORMAL 3 0.0006
308 WALKING AID USER 4 0.0006
309 SPINAL COMPRESSION FRACTURE 5 0.0006
310 PULMONARY MASS 9 0.0006
311 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 29 0.0006
312 ASPARTATE AMINOTRANSFERASE INCREASED 32 0.0006
313 ACCIDENTAL OVERDOSE 22 0.0006
314 AGEUSIA 15 0.0006
315 HYPERAMMONAEMIA 3 0.0006
316 OVERDOSE 129 0.0006
317 LEFT VENTRICULAR DYSFUNCTION 4 0.0006
318 POST-TRAUMATIC STRESS DISORDER 4 0.0006
319 CYSTITIS 19 0.0006
320 CORONARY ARTERY STENOSIS 3 0.0006
321 INTERNATIONAL NORMALISED RATIO INCREASED 17 0.0006
322 SOMNOLENCE 120 0.0006
323 CONTRAINDICATED PRODUCT ADMINISTERED 18 0.0006
324 WRONG PRODUCT ADMINISTERED 4 0.0006
325 PERIPHERAL SWELLING 91 0.0006
326 MIDDLE INSOMNIA 11 0.0006
327 FATIGUE 457 0.0006
328 IMPAIRED GASTRIC EMPTYING 8 0.0006
329 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 3 0.0006
330 VITAMIN D DECREASED 5 0.0006
331 CORONARY ARTERY OCCLUSION 8 0.0006
332 TEMPERATURE INTOLERANCE 6 0.0006
333 WHITE BLOOD CELL COUNT DECREASED 63 0.0006
334 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
335 JOINT SWELLING 70 0.0006
336 MUSCLE STRAIN 5 0.0006
337 BASAL CELL CARCINOMA 9 0.0006
338 SCHIZOPHRENIA 7 0.0006
339 PRESYNCOPE 14 0.0006
340 INCREASED APPETITE 11 0.0006
341 PETECHIAE 6 0.0006
342 FORMICATION 4 0.0006
343 FEELING COLD 16 0.0006
344 BRAIN FOG 9 0.0006
345 WEIGHT FLUCTUATION 6 0.0006
346 URINE OUTPUT DECREASED 5 0.0006
347 JOINT STIFFNESS 15 0.0006
348 DYSURIA 21 0.0006
349 CARDIOMEGALY 7 0.0006
350 BLOOD PRESSURE INCREASED 87 0.0006
351 LUNG INFILTRATION 5 0.0006
352 HEAD DISCOMFORT 10 0.0006
353 MUSCLE TWITCHING 13 0.0006
354 BONE PAIN 33 0.0006
355 FALL 187 0.0006
356 MUSCLE SPASMS 103 0.0006
357 PRODUCT SUPPLY ISSUE 4 0.0006
358 SECRETION DISCHARGE 7 0.0006
359 POOR QUALITY SLEEP 12 0.0006
360 GINGIVITIS 3 0.0006
361 ASTHENIA 209 0.0006
362 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 29 0.0006
363 BALANCE DISORDER 48 0.0006
364 HIP SURGERY 3 0.0006
365 BLOOD PRESSURE ABNORMAL 11 0.0006
366 TONGUE DISORDER 4 0.0006
367 HYPOKINESIA 8 0.0006
368 LIP DRY 5 0.0005
369 END STAGE RENAL DISEASE 10 0.0005
370 ASPIRATION 6 0.0005
371 INTENTIONAL UNDERDOSE 4 0.0005
372 DEHYDRATION 73 0.0005
373 UTERINE LEIOMYOMA 4 0.0005
374 GASTROINTESTINAL PAIN 6 0.0005
375 HEART RATE INCREASED 54 0.0005
376 INTENTIONAL SELF-INJURY 11 0.0005
377 TOOTH FRACTURE 6 0.0005
378 TINNITUS 25 0.0005
379 SKIN DISCOLOURATION 25 0.0005
380 DECREASED APPETITE 126 0.0005
381 TASTE DISORDER 11 0.0005
382 LABORATORY TEST ABNORMAL 16 0.0005
383 UROSEPSIS 5 0.0005
384 NERVE INJURY 6 0.0005
385 HEART RATE ABNORMAL 3 0.0005
386 BLOOD UREA INCREASED 9 0.0005
387 PLATELET COUNT INCREASED 7 0.0005
388 RENAL DISORDER 25 0.0005
389 HAEMOGLOBIN DECREASED 55 0.0005
390 DEFORMITY 5 0.0005
391 FIBROMYALGIA 13 0.0005
392 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 38 0.0005
393 GAIT DISTURBANCE 102 0.0005
394 PHOTOPHOBIA 10 0.0005
395 METABOLIC ACIDOSIS 17 0.0005
396 DYSARTHRIA 20 0.0005
397 HEMIPARESIS 9 0.0005
398 SQUAMOUS CELL CARCINOMA 5 0.0005
399 TOOTH INFECTION 7 0.0005
400 PAROSMIA 4 0.0005
401 DYSPHONIA 31 0.0005
402 CHOLECYSTITIS ACUTE 3 0.0005
403 MUSCULAR WEAKNESS 60 0.0005
404 IMPAIRED DRIVING ABILITY 6 0.0005
405 DIZZINESS 263 0.0005
406 SPUTUM DISCOLOURED 5 0.0005
407 INTENTIONAL DRUG MISUSE 11 0.0005
408 NEUROPATHY PERIPHERAL 50 0.0005
409 BOWEL MOVEMENT IRREGULARITY 4 0.0005
410 DEVICE PHYSICAL PROPERTY ISSUE 4 0.0005
411 FEELING HOT 32 0.0005
412 ARTHROPATHY 29 0.0005
413 QUALITY OF LIFE DECREASED 7 0.0005
414 HERPES VIRUS INFECTION 3 0.0005
415 HAEMOLYSIS 4 0.0005
416 LIMB DISCOMFORT 16 0.0005
417 OXYGEN SATURATION DECREASED 29 0.0005
418 POST PROCEDURAL HAEMORRHAGE 6 0.0005
419 MUSCULOSKELETAL PAIN 27 0.0005
420 PELVIC FRACTURE 4 0.0005
421 IRRITABLE BOWEL SYNDROME 11 0.0005
422 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
423 DYSGEUSIA 38 0.0005
424 INFLAMMATORY BOWEL DISEASE 5 0.0005
425 GASTROINTESTINAL INFLAMMATION 4 0.0005
426 PLEURAL EFFUSION 31 0.0005
427 WEIGHT DECREASED 142 0.0005
428 ENERGY INCREASED 3 0.0005
429 COVID-19 PNEUMONIA 6 0.0005
430 RESPIRATORY ARREST 14 0.0005
431 INCORRECT PRODUCT ADMINISTRATION DURATION 11 0.0005
432 BLOOD ALBUMIN DECREASED 4 0.0005
433 CARDIAC PACEMAKER INSERTION 3 0.0005
434 ANGER 17 0.0005
435 OBESITY 8 0.0005
436 SCIATICA 8 0.0005
437 MASS 7 0.0005
438 WRIST FRACTURE 6 0.0005
439 OVARIAN CYST 5 0.0005
440 BLOOD PRESSURE INADEQUATELY CONTROLLED 3 0.0005
441 CONTUSION 48 0.0005
442 URINARY TRACT INFECTION 85 0.0005
443 RASH PRURITIC 27 0.0005
444 NERVOUSNESS 26 0.0005
445 BLINDNESS UNILATERAL 7 0.0005
446 RHINORRHOEA 32 0.0005
447 FRUSTRATION TOLERANCE DECREASED 4 0.0005
448 TOOTH DISORDER 11 0.0005
449 SINUS TACHYCARDIA 7 0.0005
450 OEDEMA PERIPHERAL 60 0.0005
451 DYSKINESIA 20 0.0005
452 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 27 0.0005
453 RESTLESSNESS 18 0.0005
454 ABDOMINAL PAIN UPPER 101 0.0005
455 SLUGGISHNESS 5 0.0005
456 AGITATION 36 0.0005
457 CYTOPENIA 6 0.0005
458 RED BLOOD CELL COUNT DECREASED 14 0.0005
459 HAEMATOCHEZIA 27 0.0005
460 ALANINE AMINOTRANSFERASE INCREASED 30 0.0005
461 HYPERAESTHESIA 4 0.0005
462 HELICOBACTER INFECTION 5 0.0005
463 OSTEOPOROSIS 20 0.0005
464 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
465 HAIR DISORDER 4 0.0005
466 PARAESTHESIA ORAL 7 0.0005
467 VISUAL IMPAIRMENT 60 0.0005
468 HAIR COLOUR CHANGES 6 0.0005
469 PULMONARY HYPERTENSION 10 0.0005
470 DISORIENTATION 19 0.0005
471 HALLUCINATION 36 0.0005
472 FLATULENCE 27 0.0005
473 FULL BLOOD COUNT ABNORMAL 5 0.0005
474 FEELING JITTERY 9 0.0005
475 BLOOD CHOLESTEROL INCREASED 22 0.0005
476 RENAL PAIN 5 0.0005
477 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
478 COGNITIVE DISORDER 22 0.0005
479 CATARACT 28 0.0005
480 HYPOPHAGIA 12 0.0005
481 PULMONARY FIBROSIS 9 0.0005
482 ENTERITIS 3 0.0005
483 PRODUCT CONTAINER ISSUE 4 0.0005
484 NECK PAIN 26 0.0005
485 ERUCTATION 9 0.0005
486 NAUSEA 368 0.0005
487 HYPOAESTHESIA ORAL 7 0.0005
488 SKIN ULCER 12 0.0005
489 PSYCHOLOGICAL TRAUMA 4 0.0005
490 PRURITUS GENERALISED 10 0.0005
491 CORONARY ARTERY DISEASE 14 0.0005
492 STOMATITIS 28 0.0005
493 ANGINA UNSTABLE 3 0.0005
494 DIARRHOEA 297 0.0005
495 RESPIRATORY SYNCYTIAL VIRUS INFECTION 4 0.0005
496 BRADYPHRENIA 3 0.0005
497 PRODUCT DOSE OMISSION IN ERROR 13 0.0005
498 KIDNEY INFECTION 9 0.0005
499 BLOOD PRESSURE FLUCTUATION 11 0.0005
500 ACUTE KIDNEY INJURY 70 0.0005
501 EYE DISORDER 15 0.0005
502 INTENTIONAL DOSE OMISSION 13 0.0005
503 WHEEZING 27 0.0005
504 PHARYNGEAL OEDEMA 7 0.0005
505 EPISTAXIS 34 0.0005
506 UPPER RESPIRATORY TRACT INFECTION 21 0.0005
507 MENTAL IMPAIRMENT 11 0.0005
508 APPETITE DISORDER 3 0.0005
509 PULMONARY EMBOLISM 43 0.0005
510 PURPURA 4 0.0005
511 DENTAL CARIES 5 0.0005
512 LUNG INFECTION 7 0.0005
513 EJECTION FRACTION DECREASED 7 0.0004
514 PLATELET COUNT DECREASED 48 0.0004
515 URINARY RETENTION 15 0.0004
516 JOINT RANGE OF MOTION DECREASED 6 0.0004
517 LIVER FUNCTION TEST ABNORMAL 13 0.0004
518 VOMITING 210 0.0004
519 DEEP VEIN THROMBOSIS 29 0.0004
520 FISTULA 5 0.0004
521 PAIN IN EXTREMITY 131 0.0004
522 SYNOVITIS 8 0.0004
523 FLUSHING 45 0.0004
524 ABDOMINAL DISCOMFORT 74 0.0004
525 DRUG EFFECT INCOMPLETE 16 0.0004
526 PRODUCTIVE COUGH 21 0.0004
527 BLOOD TESTOSTERONE DECREASED 3 0.0004
528 EYE MOVEMENT DISORDER 3 0.0004
529 MICTURITION URGENCY 5 0.0004
530 MEMORY IMPAIRMENT 60 0.0004
531 SHOCK 10 0.0004
532 DROOLING 3 0.0004
533 INCORRECT DOSE ADMINISTERED 99 0.0004
534 NERVE COMPRESSION 4 0.0004
535 HYPOKALAEMIA 20 0.0004
536 DIVERTICULITIS 12 0.0004
537 MUSCLE TIGHTNESS 7 0.0004
538 OROPHARYNGEAL PAIN 40 0.0004
539 ATRIAL FIBRILLATION 42 0.0004
540 COORDINATION ABNORMAL 6 0.0004
541 SPLENOMEGALY 5 0.0004
542 INJURY 30 0.0004
543 IMPAIRED HEALING 14 0.0004
544 FEELING ABNORMAL 102 0.0004
545 BLOOD SODIUM DECREASED 8 0.0004
546 PHOTOSENSITIVITY REACTION 7 0.0004
547 DIPLOPIA 11 0.0004
548 THROAT IRRITATION 19 0.0004
549 ARTHRALGIA 176 0.0004
550 DIALYSIS 6 0.0004
551 BACK PAIN 98 0.0004
552 PSYCHOMOTOR HYPERACTIVITY 7 0.0004
553 RENAL FAILURE 56 0.0004
554 BACTERAEMIA 5 0.0004
555 HYPOAESTHESIA 63 0.0004
556 FEAR OF INJECTION 3 0.0004
557 COMA 20 0.0004
558 CHOLECYSTITIS 5 0.0004
559 PARAESTHESIA 66 0.0004
560 RECALLED PRODUCT ADMINISTERED 4 0.0004
561 HYPERLIPIDAEMIA 5 0.0004
562 ANXIETY 119 0.0004
563 HYPOACUSIS 18 0.0004
564 DEPRESSION 95 0.0004
565 ANAEMIA 79 0.0004
566 PULMONARY ARTERIAL HYPERTENSION 6 0.0004
567 LOCALISED INFECTION 10 0.0004
568 CRYING 15 0.0004
569 FAECES SOFT 3 0.0004
570 DIZZINESS POSTURAL 4 0.0004
571 BURSITIS 5 0.0004
572 RESPIRATORY FAILURE 30 0.0004
573 INTENTIONAL PRODUCT USE ISSUE 36 0.0004
574 PARKINSONISM 4 0.0004
575 BLOOD PRESSURE SYSTOLIC INCREASED 8 0.0004
576 PHARYNGEAL SWELLING 4 0.0004
577 COELIAC DISEASE 4 0.0004
578 EYE PAIN 23 0.0004
579 SMALL INTESTINAL OBSTRUCTION 5 0.0004
580 HYPOPHOSPHATAEMIA 3 0.0004
581 ARTHROPOD BITE 3 0.0004
582 ABASIA 10 0.0004
583 HAEMATOCRIT DECREASED 8 0.0004
584 GLOSSODYNIA 9 0.0004
585 SPEECH DISORDER 21 0.0004
586 VISION BLURRED 55 0.0004
587 PAIN 246 0.0004
588 INJECTION SITE DISCOLOURATION 5 0.0004
589 PRODUCT USE IN UNAPPROVED INDICATION 99 0.0004
590 PRODUCT USE ISSUE 75 0.0004
591 LOSS OF CONSCIOUSNESS 51 0.0004
592 BLOOD TRIGLYCERIDES INCREASED 7 0.0004
593 MEDICATION ERROR 22 0.0004
594 BLOOD COUNT ABNORMAL 6 0.0004
595 LYMPHADENOPATHY 14 0.0004
596 VAGINAL DISCHARGE 4 0.0004
597 HAEMOPTYSIS 11 0.0004
598 HAEMODYNAMIC INSTABILITY 3 0.0004
599 DRUG DOSE OMISSION 65 0.0004
600 FLUID RETENTION 20 0.0004
601 ABDOMINAL DISTENSION 41 0.0004
602 CHILLS 46 0.0004
603 COUGH 110 0.0004
604 BODY TEMPERATURE INCREASED 8 0.0004
605 TREMOR 65 0.0004
606 INCORRECT DRUG ADMINISTRATION DURATION 11 0.0004
607 EUPHORIC MOOD 4 0.0004
608 SINUSITIS 40 0.0004
609 GOUT 7 0.0004
610 FUNGAL INFECTION 13 0.0004
611 CONFUSIONAL STATE 63 0.0004
612 SYNCOPE 39 0.0004
613 ATRIOVENTRICULAR BLOCK 3 0.0004
614 HEADACHE 243 0.0004
615 FEMUR FRACTURE 12 0.0004
616 HAEMATOMA 10 0.0004
617 SWOLLEN TONGUE 12 0.0004
618 HAEMORRHAGIC STROKE 3 0.0004
619 TENDERNESS 4 0.0004
620 DEAFNESS 10 0.0004
621 TRANSFUSION 4 0.0004
622 WITHDRAWAL SYNDROME 16 0.0004
623 BEDRIDDEN 5 0.0004
624 PNEUMONIA 123 0.0004
625 NASOPHARYNGITIS 70 0.0004
626 IMMUNE SYSTEM DISORDER 5 0.0004
627 PULMONARY CONGESTION 5 0.0004
628 INCONTINENCE 4 0.0004
629 INFLUENZA LIKE ILLNESS 31 0.0004
630 EYE SWELLING 14 0.0004
631 ATRIAL FLUTTER 3 0.0004
632 EAR INFECTION 10 0.0004
633 RETCHING 8 0.0004
634 BODY HEIGHT DECREASED 4 0.0004
635 HYPOTENSION 75 0.0004
636 SENSORY DISTURBANCE 6 0.0004
637 CARDIAC FAILURE CONGESTIVE 30 0.0004
638 HEREDITARY ANGIOEDEMA 4 0.0004
639 LIVER FUNCTION TEST INCREASED 8 0.0004
640 SKIN CANCER 8 0.0004
641 RENAL INJURY 11 0.0004
642 BLOOD POTASSIUM INCREASED 6 0.0004
643 COLITIS 14 0.0004
644 DYSPNOEA 209 0.0004
645 FAECES DISCOLOURED 8 0.0004
646 DYSPHAGIA 35 0.0004
647 SWELLING FACE 24 0.0004
648 GASTRIC ULCER 7 0.0004
649 HYPERTENSION 78 0.0004
650 BIPOLAR DISORDER 4 0.0004
651 ASPHYXIA 3 0.0004
652 GINGIVAL BLEEDING 5 0.0004
653 OESOPHAGITIS 4 0.0004
654 IRRITABILITY 22 0.0004
655 LUNG NEOPLASM MALIGNANT 15 0.0004
656 MANIA 6 0.0004
657 SKIN LESION 10 0.0004
658 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
659 BLOOD PRESSURE DECREASED 24 0.0004
660 PROCEDURAL PAIN 10 0.0004
661 PANCREATITIS 19 0.0004
662 MALNUTRITION 4 0.0004
663 PULMONARY OEDEMA 16 0.0004
664 WEIGHT INCREASED 80 0.0004
665 RASH PAPULAR 8 0.0004
666 DRUG USE DISORDER 3 0.0004
667 SNEEZING 8 0.0004
668 SKIN INFECTION 4 0.0004
669 MIGRAINE 34 0.0004
670 HEART RATE IRREGULAR 8 0.0004
671 ABNORMAL BEHAVIOUR 14 0.0004
672 MYOCARDIAL ISCHAEMIA 4 0.0004
673 SCAB 4 0.0004
674 THERAPY CESSATION 18 0.0004
675 HYPOGLYCAEMIA 17 0.0004
676 INTERNAL HAEMORRHAGE 4 0.0003
677 RASH GENERALISED 9 0.0003
678 CHEST PAIN 64 0.0003
679 ANOSMIA 5 0.0003
680 FEEDING DISORDER 7 0.0003
681 INTESTINAL OBSTRUCTION 13 0.0003
682 SEDATION 9 0.0003
683 FLUID OVERLOAD 5 0.0003
684 BURNING SENSATION 24 0.0003
685 HIP FRACTURE 11 0.0003
686 GROIN PAIN 3 0.0003
687 GRIP STRENGTH DECREASED 3 0.0003
688 DRY EYE 17 0.0003
689 IMMUNOSUPPRESSION 3 0.0003
690 MALAISE 149 0.0003
691 LIVER DISORDER 15 0.0003
692 SKIN HAEMORRHAGE 5 0.0003
693 BLOOD CREATININE INCREASED 22 0.0003
694 FACIAL PAIN 3 0.0003
695 COLON CANCER 5 0.0003
696 MYALGIA 57 0.0003
697 GASTROINTESTINAL INFECTION 3 0.0003
698 PALPITATIONS 39 0.0003
699 MOUTH ULCERATION 7 0.0003
700 OSTEOMYELITIS 6 0.0003
701 HERPES ZOSTER 19 0.0003
702 PRODUCT SUBSTITUTION ISSUE 19 0.0003
703 SKIN DISORDER 11 0.0003
704 DEPRESSED LEVEL OF CONSCIOUSNESS 13 0.0003
705 SUICIDAL IDEATION 30 0.0003
706 JOINT INJURY 7 0.0003
707 EYE PRURITUS 11 0.0003
708 RESPIRATORY DISTRESS 9 0.0003
709 GLOMERULAR FILTRATION RATE DECREASED 4 0.0003
710 THYROID DISORDER 5 0.0003
711 DRUG ABUSE 27 0.0003
712 SURGERY 19 0.0003
713 LYMPHOMA 5 0.0003
714 OSTEONECROSIS OF JAW 8 0.0003
715 DEMENTIA 9 0.0003
716 EXPOSURE DURING PREGNANCY 20 0.0003
717 TOOTH EXTRACTION 4 0.0003
718 GASTRIC DISORDER 11 0.0003
719 BLISTER 18 0.0003
720 PNEUMONIA ASPIRATION 8 0.0003
721 MOBILITY DECREASED 23 0.0003
722 ABDOMINAL PAIN 74 0.0003
723 CYANOSIS 5 0.0003
724 INFECTION 46 0.0003
725 GLYCOSYLATED HAEMOGLOBIN INCREASED 8 0.0003
726 BLOOD URINE PRESENT 6 0.0003
727 HAEMATEMESIS 8 0.0003
728 HALLUCINATION, AUDITORY 5 0.0003
729 ULCER 5 0.0003
730 HYPERKALAEMIA 11 0.0003
731 OEDEMA 17 0.0003
732 HEART RATE DECREASED 11 0.0003
733 EYE IRRITATION 18 0.0003
734 POST PROCEDURAL COMPLICATION 6 0.0003
735 BLOOD GLUCOSE DECREASED 15 0.0003
736 GLAUCOMA 6 0.0003
737 MOVEMENT DISORDER 10 0.0003
738 INFUSION SITE PAIN 4 0.0003
739 ANOREXIA 4 0.0003
740 HIATUS HERNIA 4 0.0003
741 PLASMA CELL MYELOMA 12 0.0003
742 HEPATOMEGALY 3 0.0003
743 BODY TEMPERATURE DECREASED 3 0.0003
744 PSYCHOTIC DISORDER 9 0.0003
745 ANHEDONIA 8 0.0003
746 DISABILITY 6 0.0003
747 STAPHYLOCOCCAL INFECTION 10 0.0003
748 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
749 DEPRESSED MOOD 16 0.0003
750 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
751 GASTROINTESTINAL DISORDER 27 0.0003
752 ILLNESS 31 0.0003
753 RESPIRATORY DISORDER 9 0.0003
754 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7 0.0003
755 DRUG INTOLERANCE 29 0.0003
756 PRURITUS 115 0.0003
757 GAIT INABILITY 10 0.0003
758 HAIR TEXTURE ABNORMAL 4 0.0003
759 APHASIA 9 0.0003
760 LACRIMATION INCREASED 9 0.0003
761 INJECTION SITE MASS 11 0.0003
762 EMPHYSEMA 3 0.0003
763 BRONCHITIS 22 0.0003
764 MUSCULOSKELETAL STIFFNESS 26 0.0003
765 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
766 INFLUENZA 33 0.0003
767 PRODUCT TASTE ABNORMAL 4 0.0003
768 DRY THROAT 3 0.0003
769 CHEST DISCOMFORT 30 0.0003
770 SCAR 5 0.0003
771 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
772 PERIPHERAL COLDNESS 4 0.0003
773 CARDIAC ARREST 24 0.0003
774 ALOPECIA 57 0.0003
775 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 52 0.0003
776 HYPERHIDROSIS 37 0.0003
777 LOCAL SWELLING 5 0.0003
778 BLOOD GLUCOSE INCREASED 54 0.0003
779 APHONIA 4 0.0003
780 CONDITION AGGRAVATED 87 0.0003
781 RASH MACULAR 10 0.0003
782 ENCEPHALOPATHY 7 0.0003
783 HYPONATRAEMIA 16 0.0003
784 INJECTION SITE PRURITUS 19 0.0003
785 PAIN IN JAW 8 0.0003
786 HYPOTHYROIDISM 9 0.0003
787 THIRST 5 0.0003
788 IMPAIRED QUALITY OF LIFE 4 0.0003
789 SEPSIS 31 0.0003
790 MULTIPLE SCLEROSIS RELAPSE 19 0.0003
791 ABDOMINAL PAIN LOWER 7 0.0003
792 MYELODYSPLASTIC SYNDROME 4 0.0003
793 PRODUCT DOSE OMISSION 18 0.0003
794 DIABETES MELLITUS 21 0.0003
795 OCULAR HYPERAEMIA 13 0.0003
796 HEPATITIS 7 0.0003
797 ASCITES 8 0.0003
798 VISUAL ACUITY REDUCED 9 0.0003
799 DISEASE PROGRESSION 32 0.0003
800 DEVICE MALFUNCTION 19 0.0003
801 PHARMACEUTICAL PRODUCT COMPLAINT 7 0.0003
802 CONJUNCTIVITIS 5 0.0003
803 RESPIRATORY TRACT INFECTION 7 0.0003
804 BACTERIAL INFECTION 5 0.0003
805 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
806 INJECTION SITE ERYTHEMA 33 0.0003
807 PREMATURE BABY 8 0.0003
808 PRODUCT QUALITY ISSUE 36 0.0003
809 ECONOMIC PROBLEM 4 0.0003
810 CONVULSION 15 0.0003
811 INSURANCE ISSUE 4 0.0003
812 FEAR 7 0.0003
813 DRUG PRESCRIBING ERROR 5 0.0003
814 PAIN OF SKIN 7 0.0003
815 TACHYCARDIA 23 0.0003
816 NEOPLASM PROGRESSION 9 0.0003
817 HERNIA 5 0.0003
818 TENDONITIS 4 0.0003
819 CAESAREAN SECTION 3 0.0003
820 PYREXIA 88 0.0003
821 ARRHYTHMIA 12 0.0003
822 RASH 110 0.0003
823 DRUG INTERACTION 40 0.0003
824 UNEVALUABLE EVENT 19 0.0003
825 ABSCESS 4 0.0003
826 HAEMORRHAGE 26 0.0002
827 HEPATITIS C 3 0.0002
828 PRODUCT PHYSICAL ISSUE 5 0.0002
829 EXTRA DOSE ADMINISTERED 10 0.0002
830 RHEUMATOID ARTHRITIS 28 0.0002
831 URTICARIA 41 0.0002
832 THERAPY NON-RESPONDER 11 0.0002
833 ERYTHEMA 50 0.0002
834 HYPERCALCAEMIA 3 0.0002
835 SEIZURE 28 0.0002
836 CYST 3 0.0002
837 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
838 THROMBOCYTOPENIA 27 0.0002
839 INFUSION RELATED REACTION 16 0.0002
840 TOOTH LOSS 5 0.0002
841 VIRAL INFECTION 8 0.0002
842 OFF LABEL USE 210 0.0002
843 RHABDOMYOLYSIS 10 0.0002
844 EMOTIONAL DISTRESS 29 0.0002
845 ROAD TRAFFIC ACCIDENT 10 0.0002
846 RENAL IMPAIRMENT 20 0.0002
847 THERAPY INTERRUPTED 17 0.0002
848 DRUG DEPENDENCE 38 0.0002
849 SWELLING 22 0.0002
850 PANCYTOPENIA 13 0.0002
851 PRODUCT DOSE OMISSION ISSUE 68 0.0002
852 DELIRIUM 8 0.0002
853 MULTIPLE SCLEROSIS 11 0.0002
854 ASTHMA 26 0.0002
855 PRODUCT PRESCRIBING ISSUE 5 0.0002
856 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
857 GASTRITIS 6 0.0002
858 ANKYLOSING SPONDYLITIS 3 0.0002
859 COLD SWEAT 4 0.0002
860 LYMPHOCYTE COUNT DECREASED 4 0.0002
861 ADVERSE REACTION 3 0.0002
862 DRUG ERUPTION 4 0.0002
863 INJECTION SITE BRUISING 18 0.0002
864 INJECTION SITE HAEMORRHAGE 18 0.0002
865 SKIN EXFOLIATION 19 0.0002
866 EYE HAEMORRHAGE 3 0.0002
867 RASH MACULO-PAPULAR 5 0.0002
868 LUNG DISORDER 11 0.0002
869 CEREBROVASCULAR ACCIDENT 38 0.0002
870 CEREBRAL HAEMORRHAGE 8 0.0002
871 DRUG EFFECT DECREASED 12 0.0002
872 THROAT TIGHTNESS 6 0.0002
873 CHROMATURIA 5 0.0002
874 PALLOR 6 0.0002
875 APPLICATION SITE PRURITUS 5 0.0002
876 WRONG TECHNIQUE IN DRUG USAGE PROCESS 8 0.0002
877 MOOD ALTERED 6 0.0002
878 AGGRESSION 11 0.0002
879 TREATMENT NONCOMPLIANCE 12 0.0002
880 DRY SKIN 29 0.0002
881 ANAPHYLACTIC REACTION 12 0.0002
882 PERICARDIAL EFFUSION 5 0.0002
883 HYPERSENSITIVITY 40 0.0002
884 BLOOD TEST ABNORMAL 3 0.0002
885 DEVICE OCCLUSION 3 0.0002
886 DISCOMFORT 13 0.0002
887 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
888 THROMBOSIS 17 0.0002
889 MUSCULOSKELETAL DISORDER 4 0.0002
890 PRODUCT PRESCRIBING ERROR 5 0.0002
891 LOWER LIMB FRACTURE 4 0.0002
892 TYPE 2 DIABETES MELLITUS 7 0.0002
893 BRADYCARDIA 11 0.0002
894 HYPERTHYROIDISM 3 0.0002
895 MENTAL DISORDER 9 0.0002
896 ADVERSE EVENT 19 0.0002
897 CHOKING 4 0.0002
898 ORAL HERPES 4 0.0002
899 ACUTE MYOCARDIAL INFARCTION 6 0.0002
900 URINARY INCONTINENCE 6 0.0002
901 THERAPEUTIC PRODUCT EFFECT DECREASED 9 0.0002
902 HAEMORRHAGE INTRACRANIAL 3 0.0002
903 NEUTROPENIA 27 0.0002
904 NEUTROPHIL COUNT DECREASED 8 0.0002
905 FEBRILE NEUTROPENIA 13 0.0002
906 INJECTION SITE RASH 6 0.0002
907 DRUG INEFFECTIVE 257 0.0002
908 NEOPLASM MALIGNANT 13 0.0002
909 ERECTILE DYSFUNCTION 5 0.0002
910 ELECTROCARDIOGRAM QT PROLONGED 7 0.0002
911 INJECTION SITE WARMTH 4 0.0002
912 COVID-19 34 0.0002
913 UNRESPONSIVE TO STIMULI 5 0.0002
914 EXPOSURE VIA SKIN CONTACT 5 0.0002
915 NERVOUS SYSTEM DISORDER 6 0.0002
916 HYPERGLYCAEMIA 7 0.0002
917 BONE DENSITY DECREASED 6 0.0002
918 KNEE ARTHROPLASTY 4 0.0002
919 IMPAIRED WORK ABILITY 4 0.0002
920 MENSTRUATION IRREGULAR 5 0.0002
921 INJECTION SITE PAIN 57 0.0002
922 DISTURBANCE IN ATTENTION 10 0.0002
923 FREQUENT BOWEL MOVEMENTS 5 0.0002
924 PRODUCT DISPENSING ERROR 4 0.0002
925 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 13 0.0002
926 MELAENA 4 0.0002
927 CARDIAC DISORDER 17 0.0002
928 LEUKOPENIA 9 0.0002
929 CELLULITIS 9 0.0002
930 PANCREATITIS ACUTE 4 0.0002
931 PSORIASIS 23 0.0002
932 PRODUCT AVAILABILITY ISSUE 4 0.0002
933 MYOCARDIAL INFARCTION 30 0.0002
934 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
935 SYSTEMIC LUPUS ERYTHEMATOSUS 6 0.0002
936 DISEASE RECURRENCE 8 0.0002
937 DEATH 143 0.0002
938 ILL-DEFINED DISORDER 10 0.0002
939 UNDERDOSE 12 0.0002
940 INJECTION SITE URTICARIA 4 0.0002
941 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 33 0.0002
942 HOSPITALISATION 25 0.0002
943 BLOOD GLUCOSE ABNORMAL 3 0.0002
944 DRUG-INDUCED LIVER INJURY 5 0.0002
945 FRACTURE 3 0.0002
946 LIP SWELLING 5 0.0001
947 CARDIAC FAILURE 12 0.0001
948 DRUG WITHDRAWAL SYNDROME 13 0.0001
949 DEVICE BREAKAGE 6 0.0001
950 BLINDNESS 6 0.0001
951 GENERAL PHYSICAL HEALTH DETERIORATION 17 0.0001
952 INJECTION SITE REACTION 10 0.0001
953 DEVICE ISSUE 13 0.0001
954 INJECTION SITE SWELLING 11 0.0001
955 WOUND 4 0.0001
956 ANGINA PECTORIS 4 0.0001
957 NEEDLE ISSUE 4 0.0001
958 ANGIOEDEMA 6 0.0001
959 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
960 HEPATIC FUNCTION ABNORMAL 5 0.0001
961 ACNE 10 0.0001
962 EMOTIONAL DISORDER 4 0.0001
963 MALIGNANT NEOPLASM PROGRESSION 13 0.0001
964 LACTIC ACIDOSIS 4 0.0001
965 PSORIATIC ARTHROPATHY 5 0.0001
966 OSTEONECROSIS 4 0.0001
967 THERAPEUTIC RESPONSE SHORTENED 4 0.0001
968 CARDIOVASCULAR DISORDER 3 0.0001
969 DRUG EXPOSURE DURING PREGNANCY 4 0.0001
970 THERAPEUTIC RESPONSE DECREASED 7 0.0001
971 VAGINAL HAEMORRHAGE 5 0.0001
972 DEVICE DISLOCATION 5 0.0001
973 APPLICATION SITE ERYTHEMA 3 0.0001
974 COLITIS ULCERATIVE 5 0.0001
975 ADVERSE DRUG REACTION 10 0.0001
976 PRODUCT STORAGE ERROR 9 0.0001
977 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3 0.0001
978 EPILEPSY 3 0.0001
979 SKIN BURNING SENSATION 7 0.0001
980 ACCIDENTAL EXPOSURE TO PRODUCT 10 0.0001
981 TREATMENT FAILURE 8 0.0001
982 SEPTIC SHOCK 4 0.0001
983 DEPENDENCE 5 0.0001
984 MATERNAL EXPOSURE DURING PREGNANCY 8 0.0001
985 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
986 SKIN IRRITATION 4 0.0001
987 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4 0.0001
988 RASH ERYTHEMATOUS 4 0.0001
989 INFLAMMATION 4 0.0001
990 NO ADVERSE EVENT 14 0.0001
991 ECZEMA 4 0.0001
992 DERMATITIS ATOPIC 4 0.0001
993 DEVICE LEAKAGE 3 0.0001
994 BREAST CANCER 4 0.0000